CD8A and neoplasm: Interestingly, like Ky1043, STK-012 has been shown to induce peripheral, but not tumor-infiltrating Treg expansion and to induce expansion of CD8+ Tpex, resulting in an increased CD8/Treg ratio in the tumor, but a decreased CD8 (NK)/Treg ratio in the periphery (72).